Related references
Note: Only part of the references are listed.Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD
Kanishk Luhach et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Characterizing vulnerable brain areas and circuits in mouse models of autism: Towards understanding pathogenesis and new therapeutic approaches
Kelvin Hui et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism
Mauro Mozael Hirsch et al.
NEUROPHARMACOLOGY (2020)
Efficacy of Cilostazol Administration in Alzheimer's Disease Patients with White Matter Lesions: A Positron-Emission Tomography Study
Jun-Young Lee et al.
NEUROTHERAPEUTICS (2019)
Reduced levels of modified nucleosides in the urine of autistic children. Preliminary studies
Barbara Bobrowska-Korczak et al.
ANALYTICAL BIOCHEMISTRY (2019)
Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats
Roohi Mirza et al.
BRAIN RESEARCH BULLETIN (2019)
Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats
Roohi Mirza et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2019)
Applying vinpocetine to reverse synaptic ultrastructure by regulating BDNF-related PSD-95 in alleviating schizophrenia-like deficits in rat
Yue Xu et al.
COMPREHENSIVE PSYCHIATRY (2019)
The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models
Yu-Young Lee et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Insights into the potential antidepressant mechanisms of cilostazol in chronically restraint rats: impact on the Nrf2 pathway
Sally A. Abuelezz et al.
BEHAVIOURAL PHARMACOLOGY (2018)
Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling
Francesca Melancia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Cilostazol attenuates kainic acid-induced hippocampal cell death
Young-Seop Park et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2018)
Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model
Shireen A. Hedya et al.
MOLECULAR NEUROBIOLOGY (2018)
Transcriptional and splicing dysregulation in the prefrontal cortex in valproic acid rat model of autism
Ruoxin Zhang et al.
REPRODUCTIVE TOXICOLOGY (2018)
Selective modulator of peroxisome proliferator-activated receptor-alpha protects propionic acid induced autism-like phenotypes in rats
Roohi Mirza et al.
LIFE SCIENCES (2018)
Partial loss of psychiatric risk gene Mir137 in mice causes repetitive behavior and impairs sociability and learning via increased Pde10a
Ying Cheng et al.
NATURE NEUROSCIENCE (2018)
Cerebrolysin Prevents Deficits in Social Behavior, Repetitive Conduct, and Synaptic Inhibition in a Rat Model of Autism
Roberto Cuevas-Olguin et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Fingolimod (FTY720) attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism
Hongmei Wu et al.
LIFE SCIENCES (2017)
The Neuroprotective Effect of Curcumin Against Nicotine-Induced Neurotoxicity is Mediated by CREB-BDNF Signaling Pathway
Majid Motaghinejad et al.
NEUROCHEMICAL RESEARCH (2017)
Long-term cilostazol administration ameliorates memory decline in senescence-accelerated mouse prone 8 (SAMP8) through a dual effect on cAMP and blood-brain barrier
Shuichi Yanai et al.
NEUROPHARMACOLOGY (2017)
cAMP/PKA-CREB-BDNF signaling pathway in hippocampus mediates cyclooxygenase 2-induced learning/memory deficits of rats subjected to chronic unpredictable mild stress
Ying Luo et al.
ONCOTARGET (2017)
Targeted Interneuron Depletion in the Dorsal Striatum Produces Autism-like Behavioral Abnormalities in Male but Not Female Mice
Maximiliano Rapanelli et al.
BIOLOGICAL PSYCHIATRY (2017)
Hippocampal BDNF overexpression or microR124a silencing reduces anxiety- and autism-like behaviors in rats
Amine Bahi
BEHAVIOURAL BRAIN RESEARCH (2017)
Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke
Yu Ri Kim et al.
PSYCHOPHARMACOLOGY (2016)
Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats
Hariom Kumar et al.
BRAIN RESEARCH (2016)
Neuroprotection of Cilostazol against ischemia/reperfusion-induced cognitive deficits through inhibiting JNK3/caspase-3 by enhancing Aktl
Da-Shi Qi et al.
BRAIN RESEARCH (2016)
Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats
Hariom Kumar et al.
BRAIN RESEARCH BULLETIN (2016)
Valproic Acid Exposure during Early Postnatal Gliogenesis Leads to Autistic-like Behaviors in Rats
Tamanna Jahan Mony et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2016)
Music application alleviates short-term memory impairments through increasing cell proliferation in the hippocampus of valproic acid-induced autistic rat pups
Sung-Min Lee et al.
JOURNAL OF EXERCISE REHABILITATION (2016)
Neuroprotective effects of cilostazol are mediated by multiple mechanisms in a mouse model of permanent focal ischemia
Hideo Shichinohe et al.
BRAIN RESEARCH (2015)
Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-κB
Kenji W. Ruiz-Miyazawa et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
The Impact of Chronic Early Administration of Psychostimulants on Brain Expression of BDNF and Other Neuroplasticity-Relevant Proteins
Yaarit Simchon Tenenbaum et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2015)
Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder
Hariom Kumar et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
Efficacy of Cilostazol a selective phosphodiesterase-3 inhibitor in rat model of Streptozotocin diabetes induced vascular dementia
Ashwani Kumar et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Select 3′,5′-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain
Michy P. Kelly et al.
CELLULAR SIGNALLING (2014)
Neurovascular Protection of Cilostazol in Stroke-Prone Spontaneous Hypertensive Rats Associated With Angiogenesis and Pericyte Proliferation
Yoshio Omote et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Stereotypy after cerebellar infarction
Dongwhane Leel et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Cilostazol improves hippocampus-dependent long-term memory in mice
Shuichi Yanai et al.
PSYCHOPHARMACOLOGY (2014)
Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid
Takakuni Maki et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Commonly studied comorbid psychopathologies among persons with autism spectrum disorder
Johnny L. Matson et al.
RESEARCH IN DEVELOPMENTAL DISABILITIES (2014)
Reduced social interaction, behavioural flexibility and BDNF signalling in the BTBR T plus tf/J strain, a mouse model of autism
M. L. Scattoni et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Cilostazol Strengthens Barrier Integrity in Brain Endothelial Cells
Shoji Horai et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2013)
Differences in phosphodiesterase 3A and 3B expression after ischemic insult
Yumiko Mitome-Mishima et al.
NEUROSCIENCE RESEARCH (2013)
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Sharron H. Francis et al.
PHYSIOLOGICAL REVIEWS (2011)
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis
Diane T. Stephenson et al.
MOLECULAR AUTISM (2011)
Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: Pitfalls and solutions
Betina Elfving et al.
JOURNAL OF NEUROSCIENCE METHODS (2010)
Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
Viktor Lakics et al.
NEUROPHARMACOLOGY (2010)
Cilostazol preserves CA1 hippocampus and enhances generation of immature neuroblasts in dentate gyrus after transient forebrain ischemia in rats
Jeong Hyun Lee et al.
EXPERIMENTAL NEUROLOGY (2009)
Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine
M. Weber et al.
PSYCHOPHARMACOLOGY (2009)
Abnormal fear conditioning and amygdala processing in an animal model of autism
Kamila Markram et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion
JH Lee et al.
BRAIN RESEARCH (2006)
Cilostazol attenuates gray and white matter damage in a rodent model of focal cerebral ischemia
F Honda et al.
STROKE (2006)
Behavioral alterations in rats prenatally exposed to valproic acid: Animal model of autism
T Schneider et al.
NEUROPSYCHOPHARMACOLOGY (2005)
The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat
WCG van Staveren et al.
BRAIN RESEARCH (2001)
Differential changes in the expression of cyclic nucleotide phosphodiesterase isoforms in rat brains by chronic treatment with electroconvulsive shock
CH Cho et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2000)
Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity
T Sudo et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
